Scraping fibrosis: Expressway to the core of fibrosis
- 5 May 2011
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 17 (5), 552-553
- https://doi.org/10.1038/nm0511-552
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in miceJCI Insight, 2010
- Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose PeginterferonThe New England Journal of Medicine, 2008
- Cellular and molecular mechanisms of fibrosisThe Journal of Pathology, 2007
- Final results of a double-blind, placebo-controlled trial of the antifibrotic efficacy of interferon-γ1b in chronic hepatitis C patients with advanced fibrosis or cirrhosisHepatology, 2007
- Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSCJournal of Hepatology, 2006
- The Bone Marrow Functionally Contributes to Liver FibrosisGastroenterology, 2006
- Natural Killer Cells Ameliorate Liver Fibrosis by Killing Activated Stellate Cells in NKG2D-Dependent and Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand–Dependent MannersGastroenterology, 2006
- Decreased NK cell frequency in chronic hepatitis C does not affectex vivo cytolytic killingHepatology, 2006
- Long-term interleukin 10 therapy in chronic hepatitis C patients has a proviral and anti-inflammatory effectHepatology, 2003
- Long-term interleukin 10 therapy in chronic hepatitis C patients has a proviral and anti-inflammatory effectHepatology, 2003